Zobrazeno 1 - 10
of 2 697
pro vyhledávání: '"J Falcon"'
Autor:
Pooja Middha, Rohit Thummalapalli, Michael J. Betti, Lydia Yao, Zoe Quandt, Karmugi Balaratnam, Cosmin A. Bejan, Eduardo Cardenas, Christina J. Falcon, David M. Faleck, Princess Margaret Lung Group, Matthew A. Gubens, Scott Huntsman, Douglas B. Johnson, Linda Kachuri, Khaleeq Khan, Min Li, Christine M. Lovly, Megan H. Murray, Devalben Patel, Kristin Werking, Yaomin Xu, Luna Jia Zhan, Justin M. Balko, Geoffrey Liu, Melinda C. Aldrich, Adam J. Schoenfeld, Elad Ziv
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-10 (2024)
Abstract Immune checkpoint inhibitor-mediated colitis (IMC) is a common adverse event of treatment with immune checkpoint inhibitors (ICI). We hypothesize that genetic susceptibility to Crohn’s disease (CD) and ulcerative colitis (UC) predisposes t
Externí odkaz:
https://doaj.org/article/46e01ed1d0cc4b39bd52631c3a872a9b
Autor:
Raj, M. A., Iodice, E., Napolitano, N. R., Spavone, M., Su, H-S., Peletier, R. F., Davis, T. A., Zabel, N., Hilker, M., Mieske, S., Barroso, J. Falcon, Cantiello, M., van de Ven, G., Watkins, A. E., Salo, H., Schipani, P., Capaccioli, M., Venhola, A.
Publikováno v:
A&A 628, A4 (2019)
We present the study of a magnitude limited sample (mB < 16.6 mag) of 13 late type galaxies (LTGs), observed inside the virial radius, Rvir 0.7 Mpc, of the Fornax cluster within the Fornax Deep Survey (FDS). The main objective is to use surface brigh
Externí odkaz:
http://arxiv.org/abs/1906.08704
Autor:
Restrepo-Jaramillo, J. M.
Publikováno v:
Gregorianum, 1934 Jan 01. 15(4), 614-615.
Externí odkaz:
https://www.jstor.org/stable/23567352
Autor:
Fernandes, R. Cid, Delgado, R. M. Gonzalez, Benito, R. Garcia, Perez, E., de Amorim, A. L., Sanchez, S. F., Husemann, B., Barroso, J. Falcon, Lopez-Fernandez, R., Sanchez-Blazquez, P., Asari, N. Vale, Vazdekis, A., Walcher, C. J., Mast, D.
In a companion paper we have presented many products derived from the application of the spectral synthesis code STARLIGHT to datacubes from the CALIFA survey, including 2D maps of stellar population properties and 1D averages in the temporal and spa
Externí odkaz:
http://arxiv.org/abs/1307.0562
Autor:
Fernandes, R. Cid, Perez, E., Benito, R. Garcia, Delgado, R. M. Gonzalez, de Amorim, A. L., Sanchez, S. F., Husemann, B., Barroso, J. Falcon, Sanchez-Blazquez, P., Walcher, C. J., Mast, D.
Fossil record methods based on spectral synthesis techniques have matured over the past decade, and their application to integrated galaxy spectra fostered substantial advances on the understanding of galaxies and their evolution. Yet, because of the
Externí odkaz:
http://arxiv.org/abs/1304.5788
Autor:
Noura J. Choudhury, MD, Jaime L. Schneider, MD, PhD, Tejas Patil, MD, Viola W. Zhu, MD, PhD, Debra A. Goldman, MS, Soo-Ryum Yang, MD, Christina J. Falcon, MPH, Andrew Do, BS, Yunan Nie, MD, Andrew J. Plodkowski, MD, Jamie E. Chaft, MD, Subba R. Digumarthy, MD, Natasha Rekhtman, MD, PhD, Maria E. Arcila, MD, Alexia Iasonos, PhD, Sai-Hong I. Ou, MD, PhD, Jessica J. Lin, MD, Alexander Drilon, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 7, Pp 100187- (2021)
Introduction: ROS1 fusions are oncogenic drivers in 1% to 3% of NSCLCs. The activity of immune checkpoint inhibitor (ICI) monotherapy or in combination with chemotherapy (chemotherapy with ICI [chemo-ICI]) in these tumors and their immunophenotype ha
Externí odkaz:
https://doaj.org/article/81bc0a6f5dc849f182e47505ceaaaec1
Central Nervous System Disease in Patients With RET Fusion-Positive NSCLC Treated With Selpercatinib
Autor:
Yonina R. Murciano-Goroff, Christina J. Falcon, Sabrina T. Lin, Christina Chacko, Grace Grimaldi, Dazhi Liu, Clare Wilhelm, Alexia Iasonos, Alexander Drilon
Publikováno v:
Journal of Thoracic Oncology. 18:620-627
Autor:
Noura J. Choudhury, Antonio Marra, Jane S.Y. Sui, Jessica Flynn, Soo-Ryum Yang, Christina J. Falcon, Pier Selenica, Adam J. Schoenfeld, Natasha Rekhtman, Daniel Gomez, Michael F. Berger, Marc Ladanyi, Maria Arcila, Charles M. Rudin, Gregory J. Riely, Mark G. Kris, Glenn Heller, Jorge S. Reis-Filho, Helena A. Yu
Publikováno v:
Journal of Thoracic Oncology. 18:463-475
Preferred first-line treatment for patients with metastatic EGFR-mutant lung cancer is osimertinib, yet it is not known if patient outcomes may be improved by identifying and intervening upon molecular markers associated with therapeutic resistance.A
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
James P. Solomon, Soo-Ryum Yang, Noura J. Choudhury, Ryan N. Ptashkin, Nasrin Eslamdoost, Christina J. Falcon, Axel Martin, Andrew Plodkowski, Clare Wilhelm, Ronglai Shen, Marc Ladanyi, Michael Berger, Yanming Zhang, Alexander Drilon, Maria E. Arcila
Publikováno v:
Clin Cancer Res
Purpose: Clinical relevance thresholds and laboratory methods are poorly defined for MET amplification, a targetable biomarker across malignancies. Experimental Design: The utility of next-generation sequencing (NGS) in assessing MET copy number alte